ES2191175T3 - Procedimiento para la captacion del estado de un organismo por medicion de peptidos. - Google Patents
Procedimiento para la captacion del estado de un organismo por medicion de peptidos.Info
- Publication number
- ES2191175T3 ES2191175T3 ES97918977T ES97918977T ES2191175T3 ES 2191175 T3 ES2191175 T3 ES 2191175T3 ES 97918977 T ES97918977 T ES 97918977T ES 97918977 T ES97918977 T ES 97918977T ES 2191175 T3 ES2191175 T3 ES 2191175T3
- Authority
- ES
- Spain
- Prior art keywords
- organism
- capture
- procedure
- state
- peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
- Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction
Abstract
PROCEDIMIENTO PARA DETERMINAR EL ESTADO DE UN ORGANISMO MEDIANTE LA MEDIDA DE PEPTIDOS PROCEDENTE DE UNA MUESTRA DEL ORGANISMO, QUE CONTIENE PEPTIDOS DE ELEVADO PESO MOLECULAR Y DE BAJO PESO MOLECULAR, COMO INDICADOR PARA EL ESTADO DEL ORGANISMO, DETECTANDOSE DIRECTAMENTE PEPTIDOS DE BAJO PESO MOLECULAR, Y SE CARACTERIZAN Y SE CORRELACIONAN CON UNA REFERENCIA.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1996132521 DE19632521A1 (de) | 1996-08-13 | 1996-08-13 | Verfahren zur Gewinnung von Peptiden aus Köperflüssigkeiten und Geweben sowie Zellüberständen und zur Identifikation von krankheitsrelevanten Peptidmarkern |
DE19725362 | 1997-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2191175T3 true ES2191175T3 (es) | 2003-09-01 |
Family
ID=26028345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97918977T Expired - Lifetime ES2191175T3 (es) | 1996-08-13 | 1997-08-13 | Procedimiento para la captacion del estado de un organismo por medicion de peptidos. |
Country Status (16)
Country | Link |
---|---|
US (1) | US6875616B1 (es) |
EP (1) | EP0922226B2 (es) |
JP (1) | JP2001508864A (es) |
CN (1) | CN1233326A (es) |
AT (1) | ATE234469T1 (es) |
AU (1) | AU720626B2 (es) |
CA (1) | CA2263443C (es) |
CZ (1) | CZ294729B6 (es) |
DE (1) | DE59709517D1 (es) |
DK (1) | DK0922226T3 (es) |
EA (1) | EA001033B1 (es) |
ES (1) | ES2191175T3 (es) |
IS (1) | IS4971A (es) |
PL (1) | PL186810B1 (es) |
PT (1) | PT922226E (es) |
WO (1) | WO1998007036A1 (es) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6936424B1 (en) | 1999-11-16 | 2005-08-30 | Matritech, Inc. | Materials and methods for detection and treatment of breast cancer |
DE10021737C2 (de) * | 2000-05-04 | 2002-10-17 | Hermann Haller | Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird |
US20020160533A1 (en) | 2001-04-30 | 2002-10-31 | George Jackowski | Biopolymer marker indicative of disease state having a molecular of weight of 1525 daltons |
US6593298B2 (en) | 2001-04-30 | 2003-07-15 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons |
US7314717B2 (en) | 2001-04-30 | 2008-01-01 | Nanogen Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons |
US7008800B2 (en) | 2001-04-30 | 2006-03-07 | Artemis Proteomics, Ltd. | Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons |
US6602855B2 (en) | 2001-04-30 | 2003-08-05 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons |
US6627608B2 (en) | 2001-04-30 | 2003-09-30 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1206 daltons |
US7015004B2 (en) | 2001-11-23 | 2006-03-21 | Syn X Pharma, Inc. | Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance |
US6756476B2 (en) | 2001-04-30 | 2004-06-29 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons |
US6693080B2 (en) | 2001-04-30 | 2004-02-17 | Syn X Pharma | Biopolymer marker indicative of disease state having a molecular weight of 1521 daltons |
US7087435B2 (en) | 2001-04-30 | 2006-08-08 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons |
US6703366B2 (en) | 2001-04-30 | 2004-03-09 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltons |
US6677303B2 (en) | 2001-04-30 | 2004-01-13 | Syn X Pharma | Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons |
US6599877B2 (en) | 2001-04-30 | 2003-07-29 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1020 daltons |
US20020160420A1 (en) * | 2001-04-30 | 2002-10-31 | George Jackowski | Process for diagnosis of physiological conditions by characterization of proteomic materials |
US6627607B2 (en) | 2001-04-30 | 2003-09-30 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons |
US6890763B2 (en) | 2001-04-30 | 2005-05-10 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons |
US6627606B2 (en) | 2001-04-30 | 2003-09-30 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1465 daltons |
US6617308B2 (en) | 2001-04-30 | 2003-09-09 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons |
US6620786B2 (en) | 2001-04-30 | 2003-09-16 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having molecular weight of 2937 daltons |
US20040198950A1 (en) | 2001-04-30 | 2004-10-07 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1518 daltons |
US7294688B2 (en) | 2001-04-30 | 2007-11-13 | Nanogen Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons |
US6620787B2 (en) | 2001-04-30 | 2003-09-16 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons |
DE10123711A1 (de) * | 2001-05-15 | 2003-02-27 | Wolfgang Altmeyer | Verfahren zur Bestimmung der Herkunft biologischer Materialien |
US7179610B2 (en) | 2001-11-23 | 2007-02-20 | Nanogen Inc. | Complement C3 precursor biopolymer markers indicative of insulin resistance |
US7314762B2 (en) | 2001-11-21 | 2008-01-01 | Nanogen, Inc. | Apolipoprotein biopolymer markers indicative of insulin resistance |
US7132244B2 (en) | 2001-11-21 | 2006-11-07 | Syn X Pharma, Inc. | Betaine/GABA transport protein biopolymer marker indicative of insulin resistance |
US7052849B2 (en) | 2001-11-23 | 2006-05-30 | Syn X Pharma, Inc. | Protein biopolymer markers predictive of insulin resistance |
US20030100014A1 (en) * | 2001-11-23 | 2003-05-29 | George Jackowski | Apolipoprotein biopolymer markers predictive of type II diabetes |
US7135297B2 (en) | 2001-11-23 | 2006-11-14 | Nanogen Inc. | Protein biopolymer markers indicative of insulin resistance |
WO2003046556A2 (en) * | 2001-11-23 | 2003-06-05 | Syn.X Pharma, Inc. | Globin biopolymer markers indicative of insulin resistance |
US7026129B2 (en) | 2001-11-23 | 2006-04-11 | Syn X Pharma, Inc. | IG lambda biopolymer markers predictive of Alzheimers disease |
US6890722B2 (en) | 2001-11-23 | 2005-05-10 | Syn X Pharma, Inc. | HP biopolymer markers predictive of insulin resistance |
US7074576B2 (en) | 2001-11-23 | 2006-07-11 | Syn X Pharma, Inc. | Protein biopolymer markers indicative of alzheimer's disease |
US7094549B2 (en) | 2001-11-23 | 2006-08-22 | Syn X Pharma, Inc. | Fibronectin biopolymer marker indicative of insulin resistance |
US7122327B2 (en) | 2001-11-23 | 2006-10-17 | Nanogen Inc. | Biopolymer markers indicative of type II diabetes |
US7125678B2 (en) * | 2001-11-23 | 2006-10-24 | Nanogen, Inc. | Protein biopolymer markers predictive of type II diabetes |
US7179606B2 (en) | 2001-11-23 | 2007-02-20 | Syn X Pharma, Inc. | IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease |
US7179605B2 (en) | 2001-11-23 | 2007-02-20 | Nanogen Inc. | Fibronectin precursor biopolymer markers indicative of alzheimer's disease |
US7097989B2 (en) | 2001-11-23 | 2006-08-29 | Syn X Pharma, Inc. | Complement C3 precursor biopolymer markers predictive of type II diabetes |
WO2004089972A2 (en) | 2003-04-02 | 2004-10-21 | Merck & Co., Inc. | Mass spectrometry data analysis techniques |
DE10341193A1 (de) * | 2003-09-06 | 2005-03-31 | Mosaiques Diagnostics And Therapeutics Ag | Vorrichtung und Verfahren zur quantitativen Auswertung der in einer Körperflüssigkeitsprobe enthaltenden Polypeptide sowie Marker zur Erkennung von pathologischen Zuständen |
US20090035797A1 (en) * | 2004-10-15 | 2009-02-05 | Hancock William S | Detection of Disease Associated Proteolysis |
WO2009016431A1 (en) * | 2007-08-01 | 2009-02-05 | Digilab, Inc. | Sample preparation method and apparatus |
US10059975B2 (en) * | 2008-10-31 | 2018-08-28 | Biomerieux, Inc. | Methods for the isolation and identification of microorganisms |
CA2741008C (en) * | 2008-10-31 | 2018-08-28 | Biomerieux, Inc. | Methods for separation and characterization of microorganisms using identifier agents |
US10415075B2 (en) * | 2008-10-31 | 2019-09-17 | Biomerieux, Inc. | Method for separation, characterization and/or identification of microorganisms using mass spectrometry |
WO2013147610A2 (en) | 2012-03-30 | 2013-10-03 | Jetze Botma | Automated selection of microorganisms and identification using maldi |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5537944A (en) * | 1978-09-09 | 1980-03-17 | Seiichi Shibata | Diagnosis chemical and diagnosis method of kidney disease |
EP0651816A4 (en) * | 1992-07-15 | 1995-10-25 | Univ South Florida | LEVELS OF CCK PEPTIDES IN BLOOD IN RELATION TO THE TREATMENT OF PANIC EARTHS. |
US5492834A (en) * | 1993-07-09 | 1996-02-20 | Beckman Instruments, Inc. | Method of sample preparation for urine protein analysis with capillary electrophoresis |
DE4427531A1 (de) * | 1994-08-04 | 1996-02-08 | Forssmann Wolf Georg | Humanes zirkulierendes beta-Defensin hBD-1 |
JP3579549B2 (ja) * | 1995-10-24 | 2004-10-20 | 株式会社トクヤマ | 糖尿病または糖尿病合併症用マーカーとしての使用 |
-
1997
- 1997-08-13 CA CA002263443A patent/CA2263443C/en not_active Expired - Fee Related
- 1997-08-13 PL PL97331612A patent/PL186810B1/pl not_active IP Right Cessation
- 1997-08-13 PT PT97918977T patent/PT922226E/pt unknown
- 1997-08-13 DK DK97918977T patent/DK0922226T3/da active
- 1997-08-13 CZ CZ1999491A patent/CZ294729B6/cs not_active IP Right Cessation
- 1997-08-13 DE DE59709517T patent/DE59709517D1/de not_active Expired - Lifetime
- 1997-08-13 US US09/242,254 patent/US6875616B1/en not_active Expired - Fee Related
- 1997-08-13 AT AT97918977T patent/ATE234469T1/de not_active IP Right Cessation
- 1997-08-13 EP EP97918977A patent/EP0922226B2/de not_active Expired - Lifetime
- 1997-08-13 CN CN97198763A patent/CN1233326A/zh active Pending
- 1997-08-13 EA EA199900196A patent/EA001033B1/ru not_active IP Right Cessation
- 1997-08-13 ES ES97918977T patent/ES2191175T3/es not_active Expired - Lifetime
- 1997-08-13 WO PCT/EP1997/004396 patent/WO1998007036A1/de active IP Right Grant
- 1997-08-13 JP JP50940798A patent/JP2001508864A/ja not_active Ceased
- 1997-08-13 AU AU42988/97A patent/AU720626B2/en not_active Ceased
-
1999
- 1999-02-10 IS IS4971A patent/IS4971A/is unknown
Also Published As
Publication number | Publication date |
---|---|
US6875616B1 (en) | 2005-04-05 |
EA001033B1 (ru) | 2000-08-28 |
CN1233326A (zh) | 1999-10-27 |
WO1998007036A1 (de) | 1998-02-19 |
CZ294729B6 (cs) | 2005-03-16 |
EP0922226B2 (de) | 2008-06-25 |
DK0922226T3 (da) | 2003-07-07 |
PL331612A1 (en) | 1999-08-02 |
AU720626B2 (en) | 2000-06-08 |
PL186810B1 (pl) | 2004-02-27 |
DE59709517D1 (de) | 2003-04-17 |
EA199900196A1 (ru) | 1999-06-24 |
EP0922226A1 (de) | 1999-06-16 |
CZ49199A3 (cs) | 2000-04-12 |
ATE234469T1 (de) | 2003-03-15 |
CA2263443A1 (en) | 1998-02-19 |
AU4298897A (en) | 1998-03-06 |
PT922226E (pt) | 2003-07-31 |
EP0922226B1 (de) | 2003-03-12 |
IS4971A (is) | 1999-02-10 |
CA2263443C (en) | 2004-03-30 |
JP2001508864A (ja) | 2001-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2191175T3 (es) | Procedimiento para la captacion del estado de un organismo por medicion de peptidos. | |
DE69729444D1 (de) | Nicht-invasive messung von optisch-aktiven verbindungen | |
NO163658C (no) | Testanordning for aa teste branndetekteringssystem med fiberoptikk. | |
DE69930501D1 (de) | Ultrasensitive überwachung von sensoren und prozessen | |
EA200500056A1 (ru) | Устройство, система и способ сбора геофизических данных | |
DE69404648D1 (de) | Empfindlichkeitsprüfungsvorrichtung für rauchdetektor | |
DE60225669D1 (de) | Erlumina | |
DK0901634T3 (da) | System til bestemmelse af mindst en parameter i mindst en prøve af en fysiologisk væske samt en kassette | |
ES2181183T3 (es) | Dispositivo y procedimiento para la deteccion de un objeto en un ambito de espacio determinado, especialmente de vehiculos para la supervision de trafico. | |
DE59004587D1 (de) | Messzelle für den elektrochemischen Gasnachweis. | |
BR9607193B1 (pt) | teste de eletroquimioluscÊncia multi-especÍfico de méltiplos conjuntos. | |
ATE254765T1 (de) | Blutgerinnsel-detektor | |
BR8101641A (pt) | Instalacao de teste para um sistema medidor de comprimento ou de angulo, digital, fotoeletrico | |
NO910771L (no) | Dynamometrisk maaleinnretning for boreroer. | |
DE59813278D1 (de) | Korrektur von blutdruckmessungen bei invasiven flüssigkeitsgefüllten systemen | |
DE68914617T2 (de) | Nachweisvorrichtung für Kathodenlumineszenzanalyse. | |
ES2186121T3 (es) | Mejora de los resultados de los dosificados de inmunodeteccion gracias al empleo de varios trazadores. | |
GB2327136A (en) | Coin testing apparatus and method | |
BR9712762B1 (pt) | processo para testar a confiabilidade de um aparelho de teste, especialmente de um dispositivo para inspeção de garrafas vazias. | |
BR0015288A (pt) | Método e aparelho para o teste de um sensor | |
NO172612C (no) | Fremgangsmaate ved radiolokalisering av et fartoey som baerer en mottakingsanordning, ved maaling av forskjellene mellom tidspunktene for mottaking av radiofrekvenssignaler, og en mottakingsanordning for utfoerelse av fremgangsmaaten | |
UA26902C2 (uk) | Спосіб перевірки ступеhя точhості або hадійhості засобів вимірюваhhя і пристрій для його здійсhеhhя | |
ES2070744B1 (es) | Procedimiento y equipo para reconocimiento y analisis de los efectos de un proceso reproducible sobre una o varias magnitudes que se observan en el espacio y en el tiempo. | |
ES2164569B1 (es) | Dispositivo detector de fugas perfeccionado. | |
JPS5361920A (en) | Deterioration detecting system of mark detector |